Skip to content
TrialScanner

NCT03315689

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Phase 2CompletedACRSLead

Registry record

Lead sponsor
Aclaris Therapeutics, Inc.
Conditions
Alopecia Universalis (AU); Alopecia Totalis (AT)
Primary completion
Jun 20, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03315689 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03315689: Safety and Pharmacokinetic... | TrialScanner